Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

Mar. 25, 2025 — Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

Exercise is great for your health, strength, and quality of life. But if you have chronic lung disease, symptoms like shortness of breath may make you afraid to work out. Lung disease can ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

There are over 100 types of interstitial lung disease. Age, genetics, smoking, and medical treatments can all predispose a ...

Baylor Medicine’s Interstitial Lung Disease (ILD) program offers specialized and multidisciplinary care. We bring together a unique team of physicians of multiple sub-specialties for patients with a ...

Interstitial lung abnormalities (ILAs) are increasingly recognised due to the widespread use of low-dose computed tomography ...

Exophiala, a genus of saprotrophic black fungi commonly found in the environment, is typically associated with cutaneous infections in immunocompromised hosts and rarely manifests as pneumonia.

Lung diseases are the second leading cause of life-years lost due to disability or premature death. In Uganda, 30 percent of the hospital visits are related to lung conditions. The five major lung ...

Alveolus Bio is pioneering inhaled delivery of live biotherapeutic products (LBPs) to reduce inflammation in patients with lung diseases. Built on science from a top US respiratory center ...